EVALUATION OF THE EFFICACY AND SAFETY OF CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE IN ADULTS WITH OBESITY IN KOREA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 4 TRIAL (QUEEN’S STUDY)